Search research articles
Contact Us
Filters
Showing results (21-30 of 185) with videos related to
Page
of 19
Sort By:
International Journal of Cancer
|
May 15, 1984
Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice
P D Cooper, R B Sim
Immunology Today
|
September 1, 1991
C1: molecular interactions with activating systems
R B Sim, K B Reid
The Biochemical Journal
|
October 1, 1985
Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein
K J Micklem, R B Sim
European Journal of Biochemistry
|
May 15, 1986
Molecular modelling of human complement component C3 and its fragments by solution scattering
S J Perkins, R B Sim
Journal of Immunological Methods
|
January 4, 1993
Dye-ligand affinity purification of human complement factor B and beta 2 glycoprotein I
S C Williams, R B Sim
The Biochemical Journal
|
August 1, 1982
Purification and structural studies on the complement-system control protein beta 1H (Factor H)
R B Sim, R G DiScipio
Bioscience Reports
|
June 1, 1981
Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4
S G Davies, R B Sim
Biochemical Society Transactions
|
January 1, 1976
Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s
R B Sim, R R Porter
Biochemical Society Transactions
|
February 1, 1994
Binding sites involved in the formation of the C3 (H2O)-factor B complex of the alternative pathway of complement
S C Williams, R B Sim
FEBS Letters
|
March 29, 2000
A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2
J M Inal, R B Sim
Page
of 19
Search research articles
Search
Showing results (21-30 of 185) with videos related to
Sort By:
Page
of 19
International Journal of Cancer
|
May 15, 1984
Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice
P D Cooper, R B Sim
Immunology Today
|
September 1, 1991
C1: molecular interactions with activating systems
R B Sim, K B Reid
The Biochemical Journal
|
October 1, 1985
Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein
K J Micklem, R B Sim
European Journal of Biochemistry
|
May 15, 1986
Molecular modelling of human complement component C3 and its fragments by solution scattering
S J Perkins, R B Sim
Journal of Immunological Methods
|
January 4, 1993
Dye-ligand affinity purification of human complement factor B and beta 2 glycoprotein I
S C Williams, R B Sim
The Biochemical Journal
|
August 1, 1982
Purification and structural studies on the complement-system control protein beta 1H (Factor H)
R B Sim, R G DiScipio
Bioscience Reports
|
June 1, 1981
Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4
S G Davies, R B Sim
Biochemical Society Transactions
|
January 1, 1976
Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s
R B Sim, R R Porter
Biochemical Society Transactions
|
February 1, 1994
Binding sites involved in the formation of the C3 (H2O)-factor B complex of the alternative pathway of complement
S C Williams, R B Sim
FEBS Letters
|
March 29, 2000
A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2
J M Inal, R B Sim
Page
of 19